nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumefantrine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.169	0.17	CbGbCtD
Lumefantrine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.169	0.17	CbGbCtD
Lumefantrine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.151	0.152	CbGbCtD
Lumefantrine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.142	0.143	CbGbCtD
Lumefantrine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0959	0.0966	CbGbCtD
Lumefantrine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0915	0.0921	CbGbCtD
Lumefantrine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0816	0.0821	CbGbCtD
Lumefantrine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0479	0.0482	CbGbCtD
Lumefantrine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0452	0.0455	CbGbCtD
Lumefantrine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000755	0.114	CbGpPWpGaD
Lumefantrine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000667	0.101	CbGpPWpGaD
Lumefantrine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000546	0.0822	CbGpPWpGaD
Lumefantrine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.0417	CbGpPWpGaD
Lumefantrine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.033	CbGpPWpGaD
Lumefantrine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000212	0.032	CbGpPWpGaD
Lumefantrine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0276	CbGpPWpGaD
Lumefantrine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.0265	CbGpPWpGaD
Lumefantrine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.0248	CbGpPWpGaD
Lumefantrine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.0239	CbGpPWpGaD
Lumefantrine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.0215	CbGpPWpGaD
Lumefantrine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.0205	CbGpPWpGaD
Lumefantrine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.02	CbGpPWpGaD
Lumefantrine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.0196	CbGpPWpGaD
Lumefantrine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.0193	CbGpPWpGaD
Lumefantrine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.0188	CbGpPWpGaD
Lumefantrine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.018	CbGpPWpGaD
Lumefantrine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.0173	CbGpPWpGaD
Lumefantrine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000105	0.0159	CbGpPWpGaD
Lumefantrine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.0157	CbGpPWpGaD
Lumefantrine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	9.98e-05	0.015	CbGpPWpGaD
Lumefantrine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	9.88e-05	0.0149	CbGpPWpGaD
Lumefantrine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	9.46e-05	0.0142	CbGpPWpGaD
Lumefantrine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	8.69e-05	0.0131	CbGpPWpGaD
Lumefantrine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.0126	CbGpPWpGaD
Lumefantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	7.83e-05	0.0118	CbGpPWpGaD
Lumefantrine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.77e-05	0.0117	CbGpPWpGaD
Lumefantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.6e-05	0.0114	CbGpPWpGaD
Lumefantrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.5e-05	0.0113	CbGpPWpGaD
Lumefantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.16e-05	0.00928	CbGpPWpGaD
Lumefantrine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	6.15e-05	0.00926	CbGpPWpGaD
Lumefantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.52e-05	0.00832	CbGpPWpGaD
Lumefantrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.00821	CbGpPWpGaD
Lumefantrine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.08e-05	0.00765	CbGpPWpGaD
Lumefantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.97e-05	0.00748	CbGpPWpGaD
Lumefantrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.9e-05	0.00739	CbGpPWpGaD
Lumefantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.00674	CbGpPWpGaD
Lumefantrine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.47e-05	0.00673	CbGpPWpGaD
Lumefantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.03e-05	0.00607	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.94e-05	0.00593	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.89e-05	0.00586	CbGpPWpGaD
Lumefantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.61e-05	0.00544	CbGpPWpGaD
Lumefantrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.56e-05	0.00537	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.00493	CbGpPWpGaD
Lumefantrine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.00486	CbGpPWpGaD
Lumefantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.93e-05	0.00441	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.73e-05	0.00411	CbGpPWpGaD
Lumefantrine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.00405	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.57e-05	0.00388	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.54e-05	0.00383	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.00378	CbGpPWpGaD
Lumefantrine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.00373	CbGpPWpGaD
Lumefantrine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.00358	CbGpPWpGaD
Lumefantrine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00353	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.00322	CbGpPWpGaD
Lumefantrine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.00318	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.91e-05	0.00288	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.00269	CbGpPWpGaD
Lumefantrine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.00265	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.00247	CbGpPWpGaD
Lumefantrine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.62e-05	0.00244	CbGpPWpGaD
Lumefantrine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.00234	CbGpPWpGaD
Lumefantrine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.00231	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.00191	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.25e-05	0.00188	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.00186	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.00173	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.28e-06	0.00125	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.06e-06	0.00121	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.49e-06	0.00113	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.73e-06	0.00101	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.66e-06	0.001	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.07e-06	0.000915	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.6e-06	0.000843	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.67e-06	0.000703	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.6e-06	0.000693	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.4e-06	0.000663	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.35e-06	0.000655	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.29e-06	0.000646	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.07e-06	0.000612	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.97e-06	0.000598	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.66e-06	0.000551	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.05e-06	0.00046	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.01e-06	0.000453	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.8e-06	0.000422	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-06	0.000416	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.66e-06	0.0004	CbGpPWpGaD
Lumefantrine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-06	0.000398	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.81e-06	0.000272	CbGpPWpGaD
Lumefantrine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.73e-06	0.00026	CbGpPWpGaD
